elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34654654-FF75ECD9-5173-4756-A1D9-1E534E531CC9
Q34654654-FF75ECD9-5173-4756-A1D9-1E534E531CC9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34654654-FF75ECD9-5173-4756-A1D9-1E534E531CC9
Nv-52: a novel thromboxane synthase inhibitor for the treatment of inflammatory bowel disease.
P2860
Q34654654-FF75ECD9-5173-4756-A1D9-1E534E531CC9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34654654-FF75ECD9-5173-4756-A1D9-1E534E531CC9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1a24ba55f26cea778bb7efd5f853877efe4dc321
P2860
Risks and benefits of infliximab for the treatment of Crohn's disease